Akari Therapeutics PLC (AKTX) — Cash Flow Quality Index

Latest as of March 2023: -4.88x

Akari Therapeutics PLC (AKTX) has a Cash Flow Quality Index of -4.88x as of March 2023. Operating cash flow of $-4.88 Million is below net income of $1.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Akari Therapeutics PLC for the complete picture of this company's asset base.

Cash Flow Quality Index

-4.88x

Operating CF / Net Income

Operating Cash Flow

$-4.88 Million

USD

Net Income

$1.00 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for Akari Therapeutics PLC (None–None)

Year-by-year earnings quality comparison for Akari Therapeutics PLC. For live market cap and the full company financial profile, see how much is Akari Therapeutics PLC worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.